Pioneering siRNA-Mediated Protection of Mammalian Cells against Zika Virus (MR-766) Infection
Here, we present empirical data documenting the siRNA-mediated protection of cells after Zika virus (ZIKV) infection. siRNAs were designed to target well-conserved sequences across the ZIKV genome. Several delivery technologies were utilized. After the electroporation of 100 nM siRNA into human hepa...
Main Authors: | Benedita K. L. Feron, Joachim J. Bugert, Simon C. W. Richardson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Proceedings |
Subjects: | |
Online Access: | https://www.mdpi.com/2504-3900/50/1/45 |
Similar Items
-
siRNA lipid nanoparticles for CXCL12 silencing modulate brain immune response during Zika infection
by: Pedro Augusto Carvalho Costa, et al.
Published: (2024-01-01) -
Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery
by: Wanyi Tai
Published: (2019-06-01) -
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
by: Alexey Berezhnoy, et al.
Published: (2012-01-01) -
Engineering siRNA therapeutics: challenges and strategies
by: Syed Saqib Ali Zaidi, et al.
Published: (2023-10-01) -
Insights on prospects of nano-siRNA based approaches in treatment of Cancer
by: Rajat Goyal, et al.
Published: (2022-08-01)